Condition: Metabolomics · Critical Care · Critical Illness · Sponsor: Technical University of Munich
In this mono-center pilot trial, surgical patients who are at high risk to be admitted to intensive care will be screened and asked for participation. We are going to take blood and muscle samples at respecified time points to do metabolic, histological and molecular testing. Aim of the study is to investigate (1) changes of the blood metabolome in patients with ICUAW (intensive care unit acquired weakness) and (2) identify metabolic components who are responsible for ICUAW or can be used as marker for ICUAW.
This description comes directly from the study's public registry record.
Stefan J Schaller, MD · +4314040041020 · stefan.schaller@meduniwien.ac.at
Marian Demitsch · +4314040041020 · aai-research@muv.ac.at
Always discuss trial participation with your own doctor first.
| Medical University of Vienna | Vienna, State of Vienna, Austria | Recruiting |
| Klinikum rechts der Isar, School of Medicine, Technical University of Munich | Munich, Bavaria, Germany | Active Not Recruiting |
| Charité - Universitätsmedizin Berlin | Berlin, State of Berlin, Germany | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03810768